Notification of cessation of securities - RAD

Oct 20, 2026 at 12:19 AM EDT · Issued by Radiopharm Theranostics Limited via ASX

Filed with ASX · Oct 20, 2026 at 12:19 AM EDT · 5 pages · English

On 6ix: 6ix.com/news/notification-of-cessation-of-securities-rad

Release

Appendix 3H - Notification of cessation of securities Announcement Summary Entity name RADIOPHARM THERANOSTICS LIMITED Announcement Type New announcement Date of this announcement Tuesday October 20, 2026 Details of +securities that have ceased Number of ASX +security +securities that The...

Radiopharm Theranostics Limited on 6ix

Earlier from Radiopharm Theranostics

Non-Compliance with Listing Rule 10.11Oct 11
Radiopharm Completes Productive End-of-Phase 2 Meeting with U.S. Food and Drug Administration for Pivotal Development Program of RAD101Oct 5
RAD Completes Meeting with US FDA for Development of RAD101Oct 4
Change of Director's Interest Notice (RC)Oct 1
Appendix 4G and Corporate Governance StatementSep 30

Later from Radiopharm Theranostics

Change of Director's Interest Notices x 4Oct 20
Notification regarding unquoted securities - RADOct 20
Radiopharm receives $8M advance on FY26 R&D tax incentiveOct 26
Notice of Annual General Meeting/Proxy FormOct 26
Quarterly Activities/Appendix 4C Cash Flow ReportOct 30

All Radiopharm Theranostics news releases

Follow Radiopharm Theranostics into a list and get an email when it puts out news.

Follow Radiopharm Theranostics